Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 19 studies | 47% ± 14% | |
lung | 13 studies | 30% ± 13% | |
lymph node | 6 studies | 36% ± 11% | |
bone marrow | 4 studies | 39% ± 20% | |
intestine | 4 studies | 22% ± 7% | |
liver | 4 studies | 44% ± 25% | |
kidney | 3 studies | 38% ± 16% | |
uterus | 3 studies | 33% ± 13% | |
brain | 3 studies | 22% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 99% | 4491.47 | 649 / 653 | 97% | 400.60 | 586 / 605 |
breast | 99% | 3752.38 | 455 / 459 | 93% | 221.18 | 1045 / 1118 |
lung | 99% | 4789.24 | 573 / 578 | 91% | 164.67 | 1047 / 1155 |
stomach | 91% | 1891.33 | 325 / 359 | 77% | 111.03 | 219 / 286 |
kidney | 88% | 2063.62 | 78 / 89 | 73% | 85.76 | 656 / 901 |
intestine | 83% | 2401.94 | 802 / 966 | 77% | 86.18 | 405 / 527 |
bladder | 71% | 2003.67 | 15 / 21 | 83% | 169.80 | 417 / 504 |
adrenal gland | 91% | 1963.60 | 236 / 258 | 46% | 44.33 | 106 / 230 |
esophagus | 52% | 705.43 | 750 / 1445 | 70% | 87.67 | 129 / 183 |
prostate | 82% | 1367.68 | 200 / 245 | 33% | 28.57 | 166 / 502 |
ovary | 10% | 111.13 | 18 / 180 | 100% | 567.82 | 429 / 430 |
uterus | 21% | 376.61 | 36 / 170 | 84% | 137.52 | 387 / 459 |
pancreas | 21% | 235.96 | 68 / 328 | 84% | 103.64 | 149 / 178 |
lymph node | 0% | 0 | 0 / 0 | 100% | 722.29 | 29 / 29 |
peripheral blood | 100% | 15716.73 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 18024.91 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 239.21 | 1 / 1 |
muscle | 100% | 5686.32 | 801 / 803 | 0% | 0 | 0 / 0 |
adipose | 97% | 3935.33 | 1173 / 1204 | 0% | 0 | 0 / 0 |
skin | 28% | 360.95 | 511 / 1809 | 66% | 91.53 | 310 / 472 |
tonsil | 0% | 0 | 0 / 0 | 93% | 139.91 | 42 / 45 |
brain | 30% | 412.97 | 795 / 2642 | 54% | 54.69 | 380 / 705 |
blood vessel | 55% | 955.76 | 729 / 1335 | 0% | 0 | 0 / 0 |
liver | 20% | 298.20 | 45 / 226 | 19% | 18.23 | 78 / 406 |
heart | 37% | 450.13 | 317 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 15% | 11.81 | 12 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0070778 | Biological process | L-aspartate transmembrane transport |
GO_0071333 | Biological process | cellular response to glucose stimulus |
GO_0000266 | Biological process | mitochondrial fission |
GO_0032869 | Biological process | cellular response to insulin stimulus |
GO_1990542 | Biological process | mitochondrial transmembrane transport |
GO_0070542 | Biological process | response to fatty acid |
GO_0006096 | Biological process | glycolytic process |
GO_0015909 | Biological process | long-chain fatty acid transport |
GO_0030225 | Biological process | macrophage differentiation |
GO_0000303 | Biological process | response to superoxide |
GO_0006541 | Biological process | glutamine metabolic process |
GO_1990845 | Biological process | adaptive thermogenesis |
GO_0072593 | Biological process | reactive oxygen species metabolic process |
GO_0051881 | Biological process | regulation of mitochondrial membrane potential |
GO_0071548 | Biological process | response to dexamethasone |
GO_1902356 | Biological process | oxaloacetate(2-) transmembrane transport |
GO_0110099 | Biological process | negative regulation of calcium import into the mitochondrion |
GO_0097421 | Biological process | liver regeneration |
GO_1902476 | Biological process | chloride transmembrane transport |
GO_0009409 | Biological process | response to cold |
GO_0001666 | Biological process | response to hypoxia |
GO_1902358 | Biological process | sulfate transmembrane transport |
GO_0034198 | Biological process | cellular response to amino acid starvation |
GO_0120162 | Biological process | positive regulation of cold-induced thermogenesis |
GO_0015740 | Biological process | C4-dicarboxylate transport |
GO_0061179 | Biological process | negative regulation of insulin secretion involved in cellular response to glucose stimulus |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_0071423 | Biological process | malate transmembrane transport |
GO_1902600 | Biological process | proton transmembrane transport |
GO_0071284 | Biological process | cellular response to lead ion |
GO_0005739 | Cellular component | mitochondrion |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0019003 | Molecular function | GDP binding |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0015078 | Molecular function | proton transmembrane transporter activity |
GO_0015183 | Molecular function | L-aspartate transmembrane transporter activity |
GO_0015297 | Molecular function | antiporter activity |
GO_0015131 | Molecular function | oxaloacetate transmembrane transporter activity |
GO_0140787 | Molecular function | phosphate ion uniporter activity |
GO_0008271 | Molecular function | secondary active sulfate transmembrane transporter activity |
GO_0015108 | Molecular function | chloride transmembrane transporter activity |
GO_0017077 | Molecular function | oxidative phosphorylation uncoupler activity |
GO_0005515 | Molecular function | protein binding |
GO_0015140 | Molecular function | malate transmembrane transporter activity |
Gene name | UCP2 |
Protein name | Uncoupling protein 2 Dicarboxylate carrier SLC25A8 (Mitochondrial uncoupling protein 2) (UCP 2) (Solute carrier family 25 member 8) (UCPH) Dicarboxylate carrier SLC25A8 (Mitochondrial uncoupling protein 2) (Solute carrier family 25 member 8) |
Synonyms | SLC25A8 |
Description | FUNCTION: Antiporter that exports dicarboxylate intermediates of the Krebs cycle in exchange for phosphate plus a proton across the inner membrane of mitochondria, a process driven by mitochondrial motive force with an overall impact on glycolysis, glutaminolysis and glutathione-dependent redox balance. Continuous export of oxaloacetate and related four-carbon dicarboxylates from mitochondrial matrix into the cytosol negatively regulates the oxidation of acetyl-CoA substrates via the Krebs cycle, lowering the ATP/ADP ratio and reactive oxygen species (ROS) production . Proton transporter activity is debated, but if it occurs it may mediate inducible proton re-entry into the mitochondrial matrix affecting ATP turnover as a protection mechanism against oxidative stress. Proton re-entry may be coupled to metabolite transport to allow for proton flux switching and optimal ATP turnover (By similarity). Regulates the use of glucose as a source of energy. Required for glucose-induced DRP1-dependent mitochondrial fission and neuron activation in the ventromedial nucleus of the hypothalamus (VMH). This mitochondrial adaptation mechanism modulates the VMH pool of glucose-excited neurons with an impact on systemic glucose homeostasis (By similarity). Regulates ROS levels and metabolic reprogramming of macrophages during the resolution phase of inflammation. Attenuates ROS production in response to IL33 to preserve the integrity of the Krebs cycle required for persistent production of itaconate and subsequent GATA3-dependent differentiation of inflammation-resolving alternatively activated macrophages (By similarity). Can unidirectionally transport anions including L-malate, L-aspartate, phosphate and chloride ions . Does not mediate adaptive thermogenesis (By similarity). . |
Accessions | ENST00000663595.2 ENST00000310473.9 ENST00000545212.1 H0YFQ0 P55851 F5GX45 F5H312 ENST00000539764.1 ENST00000536983.5 |